Analyzing the impact of injecting platelet-rich plasma on molar tooth movement

ISRCTN ISRCTN47495953
DOI https://doi.org/10.1186/ISRCTN47495953
Secondary identifying numbers researchregistry9722
Submission date
24/03/2024
Registration date
26/03/2024
Last edited
26/03/2024
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
The utilization of platelet-rich plasma (PRP) in dentistry has been ongoing for several decades. However, its practical application in orthodontics still demands more thorough examination. The objective of this research was to assess the potential impacts of injecting PRP locally on the speed and nature of movement of mandibular second molars forward compared to a control group.

Who can participate?
Patients aged 17 - 25 years who require lower molar protraction

What does the study involve?
Patients were randomly chosen to participate in a study where their mouths were divided into two halves. One half received injections of platelet-rich plasma (PRP) before starting the protraction process (PRP group), while the other half received only saline solution (comparator group). To be eligible for the study, patients needed to have their lower first molars removed on both sides for at least a year, and their lower second molars needed to be ready for protraction. The main focus of the study was to measure how quickly the molars moved forward from the beginning of the protraction process until the end of the seventh month, using a digital gauge. Another aspect was to determine the type of movement of the second molars during protraction by examining side-view X-ray images before protraction (T0) and after seven months (TF). The decision about which side received the PRP injection was made randomly by selecting envelopes that were opaque and sealed. While it wasn't possible to keep the principal investigator unaware of the treatment, the patients were kept unaware by injecting saline solution on the other side.

What are the possible benefits and risks of participating?
Not provided at time of registration

Where is the study run from?
University of Aleppo (Syria)

When is the study starting and how long is it expected to run for?
September 2020 to February 2024

Who is funding the study?
University of Aleppo (Syria)

Who is the main contact?
amerkhatib82@gmail.com
ferasbaba72@gmail.com

Contact information

Dr Amer Khatib
Public, Scientific, Principal Investigator

Shahbaa street
Aleppo
15310
Syria

ORCiD logoORCID ID 0009-0009-0788-8042
Phone +963 992452493
Email khateeb_485@alepuniv.edu.sy
Prof Feras Baba
Scientific

Shahbaa street
Aleppo
15310
Syria

Phone +963 955590631
Email ferasbaba72@gmail.com

Study information

Study designInterventional randomized controlled clinical trial split mouth design
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)University/medical school/dental school
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet.
Scientific titleEvaluating the injection of platelet-rich plasma on second lower molars protraction: a randomized controlled clinical trial
Study objectivesInjection of PRP accelerates lower molar protraction
Ethics approval(s)

Approved 08/03/2020, University of Aleppo Ethics Committee (Dental College, University of Aleppo, Aleppo, -, Syria; -; sr.srd@damascusuniversity.edu.sy), ref: UADS-2401-08032020/SRC-1036

Health condition(s) or problem(s) studiedPatients with bilaterally extracted mandibular first molars
InterventionPatients were randomly allocated in a split-mouth study design to receive PRP injections on one side (PRP group) immediately before the start of protraction, while the other side received only saline solution (comparator group).
20 ml of blood was directly collected by butterfly scalp vein from the patient to sterile tubes with ACD-A as an anticoagulant. One millilitre of the blood sample was set apart to determine the concentration of platelets. PRP was prepared by the double-spin technique as described by Marx and Garg with modifications; initially, the blood was centrifuged at 1600 rpm for 4 minutes to separate the plasma containing the platelets from the red cells. The plasma was drawn off the top and centrifuged for an additional 6 minutes at 3500 rpm to get PRP.
Follow up for 7 months.
Intervention typeBiological/Vaccine
Pharmaceutical study type(s)Not Applicable
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Platelet-rich plasma
Primary outcome measureRate of molar protraction from the beginning of protraction and the end of the seventh month, using a digital gauge
Secondary outcome measuresType of movement of second molar protraction by lateral cephalometric images before molar protraction (T0) and after seven months of molar protraction (TF)
Overall study start date01/09/2020
Completion date10/02/2024

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit17 Years
Upper age limit25 Years
SexBoth
Target number of participants18
Total final enrolment15
Key inclusion criteria1. Aged between from 17 and 25 years
2. Have all lower permanent teeth present, including intact third molar, but the bilateral first permanent lower molar were extracted and indicated mandibular second molars protraction, in which extractions were done at least one year ago to ensure complete extraction socket cortication and at most 3 years to avoid severely inclined second lower molars, or severely reduced alveolar bone height and width
Key exclusion criteria1. Have undergone previous orthodontic treatment
2. Have poor oral hygiene
3. Systemic disease especially those with coagulation problems or who are being treated with anticoagulants and NSAIDS
4. Unilateral chewing or extra-functional habits.
Date of first enrolment01/09/2020
Date of final enrolment10/01/2022

Locations

Countries of recruitment

  • Syria

Study participating centre

Aleppo University
Shahbaa street
Aleppo
15310
Syria

Sponsor information

University of Aleppo
University/education

Shahbaa street
Aleppo
15310
Syria

Phone +963 944298555
Email cmoffice@alepuniv.edu.sy
Website http://www.alepuniv.com/
ROR logo "ROR" https://ror.org/03mzvxz96

Funders

Funder type

University/education

University of Aleppo
Government organisation / Universities (academic only)
Alternative name(s)
Aleppo University, جَامِعَة حَلَب, UOA
Location
Syria

Results and Publications

Intention to publish date01/06/2024
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal
IPD sharing planThe datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request
amerkhatib82@gmail.com

Editorial Notes

26/03/2024: Trial's existence confirmed by University of Aleppo Ethics Committee.